Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online July 26, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0212v1
25/11/2797    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trzaska, K. A.
Right arrow Articles by Rameshwar, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trzaska, K. A.
Right arrow Articles by Rameshwar, P.
Submitted on March 24, 2007
Accepted on July 16, 2007

TISSUE-SPECIFIC STEM CELLS

Specification of a Dopaminergic Phenotype from Adult Human Mesenchymal Stem Cells

Katarzyna A. Trzaska 1, Eldo V. Kuzhikandathil 2, Pranela Rameshwar 3*

1 Graduate School of Biomedical Sciences, Department of Medicine Hematology/Oncology, University of Medicine and Dentistry of New Jersey – New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey, USA.
2 Department of Pharmacology Physiology
3 Department of Medicine Hematology/Oncology, University of Medicine and Dentistry of New Jersey – New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey, USA.

* To whom correspondence should be addressed. E-mail: rameshwa{at}umdnj.edu.


   Abstract

Dopamine (DA) neurons derived from stem cells are a valuable source for cell replacement therapy in Parkinson's disease (PD), to study the molecular mechanisms of DA neuron development, and for screening pharmaceutical compounds that target DA disorders. Compared to other stem cells, mesenchymal stem cells (MSCs) derived from the adult human bone marrow (BM) have significant advantages and greater potential for immediate clinical application. We report the identification of in vitro conditions for inducing adult human MSCs into DA cells. Using a cocktail that includes sonic hedgehog (SHH) and fibroblast growth factors (FGF8 and bFGF), human BM-derived MSCs were induced in vitro to become DA cells in 12 days. Based on tyrosine hydroxylase (TH) expression, the efficiency of induction was determined to be ~67%. The cells develop a neuronal morphology expressing the neuronal markers NeuN and {beta} III tubulin, but not glial markers, GFAP and Olig2. As the cells acquire a post-mitotic neuronal fate, they down-regulate cell cycle activator proteins cyclin B, cdk2 and PCNA. Molecular characterization revealed the expression of DA specific genes such as TH, Pitx3, Nurr1, DAT and VMAT2. The induced MSCs also synthesize and secrete DA in a depolarization-independent manner. The latter observation is consistent with the low expression of voltage gated Na+ and Ca2+ channels in the induced MSCs and suggests that the cells are at an immature stage of development likely representing DA neuronal progenitors. Taken together, the results demonstrate the ability of adult human BM-derived MSCs to form DA cells in vitro.

Key Words. dopamine, stem cells, Parkinson's disease, neural repair







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2007 by AlphaMed Press.